Advertisement
Editorial| Volume 136, P125-126, June 2023

Download started.

Ok

UK guidelines for the management of norovirus outbreaks in acute and community health and social care settings 2023

Published:April 25, 2023DOI:https://doi.org/10.1016/j.jhin.2023.04.011
      UK guidelines for the management of norovirus outbreaks in acute and community health and social care settings, presented in this issue [
      • Chadwick P.R.
      • Trainor E.
      • Marsden G.L.
      • Mills S.
      • Chadwick C.
      • O'Brien S.J.
      • et al.
      Guidelines for the management of norovirus outbreaks in acute and community health and social care settings.
      ] of the Journal of Hospital Infection, represent the first update to these guidelines in just over a decade [
      Norovirus Working Party
      Guidelines for the management of norovirus outbreaks in acute and community health and social care settings.
      ]. A lot has changed in the world of infection, prevention and control (IPC) since then, namely the coronavirus pandemic. Norovirus, or the ubiquitous ‘winter vomiting bug’ as it is also known, remains the most common cause of acute gastroenteritis worldwide and outbreaks continue to have significant impacts upon health and social care systems. Like influenza, noroviruses encompass a diverse and constantly evolving group of RNA viruses. At least since the mid-1990s variants belonging to the genogroup II-genotype 4 (GII.4) strain have been responsible for the majority of outbreaks and sporadic disease observed worldwide, with the last major variant causing global outbreaks (GII.4 Sydney) identified in 2012 [
      • van Beek J.
      • Ambert-Balay K.
      • Botteldoorn N.
      • Eden J.S.
      • Fonager J.
      • Hewitt J.
      • et al.
      Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012.
      ]. Since then, there is evidence [
      • de Graaf M.
      • van Beek J.
      • Vennema H.
      • Podkolzin A.T.
      • Hewitt J.
      • Bucardo F.
      • et al.
      Emergence of a novel GII.17 norovirus – end of the GII.4 era?.
      ] to suggest emergence of non-GII.4 strains in some parts of the world, highlighting the importance of robust surveillance systems in anticipating new noroviruses with global outbreak potential and informing vaccine formulations, as and when they become available.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chadwick P.R.
        • Trainor E.
        • Marsden G.L.
        • Mills S.
        • Chadwick C.
        • O'Brien S.J.
        • et al.
        Guidelines for the management of norovirus outbreaks in acute and community health and social care settings.
        J Hosp Infect. 2023; https://doi.org/10.1016/j.jhin.2023.01.017
        • Norovirus Working Party
        Guidelines for the management of norovirus outbreaks in acute and community health and social care settings.
        Norovirus Working Party, 2012 (Available at:) ([last accessed April 2023])
        • van Beek J.
        • Ambert-Balay K.
        • Botteldoorn N.
        • Eden J.S.
        • Fonager J.
        • Hewitt J.
        • et al.
        Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012.
        Euro Surveill. 2013; 18: 8-9
        • de Graaf M.
        • van Beek J.
        • Vennema H.
        • Podkolzin A.T.
        • Hewitt J.
        • Bucardo F.
        • et al.
        Emergence of a novel GII.17 norovirus – end of the GII.4 era?.
        Euro Surveill. 2015; 2021178
        • National Institute for Health and Care Excellence
        Accreditation.
        2023 (Available at:) ([last accessed April 2023])
        • Coia J.E.
        • Wilson J.A.
        • Bak A.
        • Marsden G.L.
        • Shimonovich M.
        • Loveday H.P.
        • et al.
        Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities.
        J Hosp Infect. 2021; 118S (Erratum in: J Hosp Infect, 2022; 125:92-93): S1-S39
        • Grade Working Group
        From evidence to recommendations – transparent and sensible.
        2023 (Available at:) ([last accessed April 2023])